Explore expert articles from our top publications in the newest issue of our free newsletter: Citeline Editors' Picks. In this issue we are covering Rare Disease Day, the future of US life sciences, animal testing, and more!? ? Subscribe today for expert analysis on pharma, medtech, and consumer health.
关于我们
Citeline is a leading global provider of data, analytics, and insights to the life sciences and pharmaceutical industries. With a focus on accelerating drug development and improving clinical outcomes, Citeline empowers organizations to make data-driven decisions at every stage of the drug lifecycle. We offer innovative solutions in clinical trial data, drug development intelligence, regulatory insights, and competitive intelligence. Our services help pharmaceutical companies, contract research organizations (CROs), and biotech firms reduce risks, optimize resources, and increase the success rate of clinical trials. Our unique blend of advanced technology, expert analysis, and industry expertise is what sets us apart. We utilize AI-powered tools, curated databases, and expert-led research to provide actionable intelligence that drives business decisions. Citeline’s core offerings include: ClinicalTrials.gov Data: Providing real-time access to comprehensive global clinical trial data, enabling faster, more informed decisions. Drug Development Intelligence: In-depth research and insights on drug pipelines, market opportunities, and competitive dynamics to enhance strategic planning. Regulatory Intelligence: Streamlined insights on regulatory requirements, approval processes, and compliance to ensure seamless product development and market entry. Competitive Intelligence: Actionable insights into the competitive landscape, helping organizations stay ahead of emerging trends, opportunities, and potential risks. With years of experience in serving top pharmaceutical companies and organizations worldwide, we have earned a reputation for delivering accurate, timely, and reliable data solutions. Our customers trust us to help them navigate the complexities of drug development and stay competitive in a fast-evolving market. At Citeline, we’re committed to innovation, excellence, and collaboration.
- 网站
-
https://www.citeline.com/
Citeline的外部链接
- 所属行业
- 信息服务
- 规模
- 501-1,000 人
- 总部
- New York，New York
- 类型
- 私人持股
地点
Citeline员工
-
John Hughes
Vice President, Global Business Development @ Citeline / Evaluate | Healthcare & Life Sciences Commercial Leader | Value Creator
-
Darcy Grabenstein (she/her), APR, ABC
Amplifying Citeline's industry-leading data and thought leadership to help connect patients to treatments and improve outcomes
-
David Wild
-
Anthony DeSalvatore
动态
-
We are thrilled to welcome our latest sponsor Adalvo who are sponsoring API Supplier of the Year category at this year's Global Generics & Biosimilars Awards. Entries for the Awards are open until Friday, 1 August, 2025 - get started on your entries today to be in with a chance of winning! ?? https://lnkd.in/eATvw3Nv #GGBAwards
-
-
Download 5 key articles from our expert journalists at Pink Sheet: https://ow.ly/A0Jp50UnNve. While U.S. political events are capturing headlines, significant pharma reform legislation is advancing in the EU—poised to impact everything from manufacturing practices to market exclusivity. This article bundle unpacks these transformative changes, outlining what’s already decided and what’s still in motion. Gain essential insights on how these reforms could reshape the pharmaceutical landscape in Europe and what it means for the future of your business. _____ Follow Citeline Regulatory, giving you the information, tools, and services needed to maintain clinical trial disclosure compliance, mitigate risk, and increase transparency.
-
-
We're thrilled to attend CDMO Live, happening May 7-8, 2025: https://ow.ly/UjtQ50VajRG. This is an exclusive event bringing together the sharpest minds in biopharma outsourcing. Meet Roberta Ricciotti at the event and be sure to register now! https://ow.ly/F7Mh50VajRH.
-
-
Pharma’s biggest trends are here: https://ow.ly/ysOg50VjYbO. The 33rd annual Pharma R&D Review covers it all—pipeline shifts by company, therapeutic area, and drug type. Whether you're monitoring competitors or planning your next move, this report has the insights you need.? Get the full report now: https://ow.ly/ysOg50VjYbO #RD25 _____ Follow Citeline, the leading provider of drug, device, company, clinical trial, and market intelligence in the pharmaceutical and medtech markets.
-
Citeline转发了
There is still an unmet need for new and different obesity therapeutic interventions: https://ow.ly/Th0k50VeUNo. Tim Blackstock, Citeline's Cardiovascular and Metabolic & Infectious Diseases Therapy Area Director, comments in a recent BioXconomy article on the AbbVie/Gubra deal. Read the full article: https://ow.ly/Th0k50VeUNo. #Ozempic #Wegovy #Mounjaro _____ Follow Citeline, the leading provider of drug, device, company, clinical trial, and market intelligence in the pharmaceutical and medtech markets.
-
-
Citeline转发了
China has started appearing as the key player in the clinical trial landscape globally in terms of the growing number of global clinical trials initiated in the country. https://ow.ly/PJCZ50UkfBt Janelle Hart, Managing Editor, Custom Content at Citeline, a Norstella company, sits down with Xu Hu and Jie (Dexter) Yan, senior APAC reporters at Citeline, to discuss key trends and ongoing barriers impacting drug development in China and the future Chinese pharma market. Click the link in this post for access to the full article. #ClinicalTrials #ChinaBiotech #APACPharma #BiotechTrends #PharmaceuticalResearch
-
-
Norstella, Citeline's parent company,?has been named to?Fast Company's list of the World’s Most Innovative Companies for 2025!
Norstella has been named to Fast Company's list of the World’s Most Innovative Companies for 2025, highlighting our unwavering commitment to securing patient access to life-saving treatments and revolutionizing the pharma intelligence landscape. https://ow.ly/Juk250Vj7L7 Read our press release to find out more about this recognition. #FCMostInnovative
-
-
Enter today! The Global Generics & Biosimilars Awards 2025 features categories celebrating diverse achievements across the global off-patent pharmaceutical industry such as: ? Biosimilar Initiative of the Year: Recognizing initiatives driving biosimilar adoption, from development to market success. ? Leader of the Year: Honoring senior leaders in generics and biosimilars for strategic vision, growth, and industry impact. ? Industry Partner of the Year: Recognizing excellence among firms and individuals supporting generics and biosimilars industries. Does your company fit these descriptions? Submit your entries today! Entries close: Friday, 1 August, 2025 https://ow.ly/AMaB50V9tYb #GGBAwards #AwardCategories #OffPatent
-
-
Come see us at #BIOEuropeSpring booth #78!
Day one is done ?? and day two will be even better!! We’re here at #BIOEuropeSpring bringing our thought leadership to Milan. At Citeline booth #78 I encourage you to: ??Play our Name That Sponsor game for a chance to win an Oura Ring Gen3 ?Stop by for legendary barista-brewed coffee from Fogarolli ??Chat with our experts and experience first-hand how our products can transform your workflow ??PLUS: Don't miss our fireside chat with Laura A. Lane from Eli Lilly and Company and Jo Shorthouse on 18 March at 11:30 in Coral 2. Jo Shorthouse Emilie Moussin Jean-Marc Mezin Mandy Choong Danielle Adamson Rashed Qureshi Emily Carter-Richardson Ellie Davenport Vince Spurr Andrew Davis David Palmer John Champney Harry Dobson
-